The resignation of head drug regulator George Tidmarsh comes amid concerns about conduct related to the lupus nephritis drug ...

A growing number of FDA employees are eyeing the exits as chaos and uncertainty sweep through the agency, according to ...

George Tidmarsh, the newly installed director of the FDA’s Center for Drug Evaluation and Research, was placed on leave ...

Dr. George Tidmarsh, who joined the FDA in July, stepped down Sunday, The New York Times reported. His resignation came just ...

It was the latest shockwave to sweep through an agency beset by all kinds of tumult in recent months. In interviews, ...

A lawsuit filed against George Tidmarsh, who resigned from a top FDA post on Sunday, includes a series of incendiary texts ...

Less than 24 hours after resigning his post as the FDA’s head drug regulator, George Tidmarsh is reportedly reconsidering his decision and vowing to fight for his name and credibility amid a probe ...

A federal spokesperson said Dr. George Tidmarsh left the agency after federal lawyers began looking into “serious concerns ...

Aurinia Pharmaceuticals (AUPH) stock gains as the company's Q3 2025 results beat forecasts despite an FDA information request ...

Dr. George Tidmarsh was placed on administrative leave for an allegation he has denied, claiming the move is in retaliation ...

The latest turmoil within Commissioner Marty Makary’s Food and Drug Administration, an alleged bribery scandal involving a ...